Show/hide main menu

Basson Lab

Research Projects


Development of the cerebellum

A major focus of the laboratory has been to understand how mammalian cerebellum develops. We are examining the mechanisms necessary for establishing and maintaining early cerebellar progenitors during regionalisation of the embryonic neural tube and the mechanisms that regulate the proliferation and differentiation of cerebellar granule neuron progenitors during early postnatal life (Yu et al. (2011) Development 138: 2957-2968). The cerebellum is essential for fine motor control and cerebellar defects can result in ataxia. In addition, the cerebellum has been implicated in cognition and cerebellar hypoplasia and is associated with a number of important neurodevelopmental disorders, including autism (Basson & Wingate (2013) Front Neuroanat. 7:29). Our research therefore, has important implications for understanding the genetic and epigenetic causes of cerebellar hypoplasia, ataxia, autism and cerebellar tumours (medulloblastoma).

By manipulating the levels of FGF signalling during brain development in the mouse, we have identified a specific region of the cerebellum, the vermis, which is particularly sensitive to reductions in FGF signalling (Basson et al. (2008) Development 135: 889-898). These findings led to the hypothesis that epigenetic alterations that affect FGF gene expression and signalling in the embryonic mid-hindbrain region will be associated with vermis hypoplasia in the human population. 


Above Image: The mouse cerebellum in wholemount (left), sagittal section (middle) and after immunohistochemistry for PCP2 to visualize developing Purkinje neurons in a postnatal day 7 cerebellum.

Chromatin remodelling factors in neural development and autism


CHD7 and CHARGE syndrome



The CHD7 gene is mutated in human CHARGE syndrome, a rare, but devastating syndrome that affects multiple organs. CHD7 primarily associates with distal enhancers where it appears to function as a “rheostat” that fine-tunes the expression levels of developmentally important genes. 

Image: CHD7 is associated with distal gene enhancers, where it interacts with other chromatin remodelling complexes and presumably affects gene expression by remodelling chromatin. 




In collaboration with Pete Scambler’s group at the UCL Institute for Child Health, we have developed mouse models, which allow us to study the developmental causes of brain defects associated with this syndrome. Using these models, we recently identified CHD7 as a key regulator of homeobox gene expression in the developing neural tube and found that de-regulated homeobox gene expression was associated with reduced FGF gene expression and signalling. This finding led to a collaboration with Conny van Ravenswaaij-Arts in the Netherlands, which identified cerebellar hypoplasia in a significant proportion of CHARGE syndrome patients (Yu et al. (2013) eLife 2:e01305, Basson (2014) Rare Diseases 2: e28688).

We have identified additional roles for CHD7 in neural stem cell quiescence in the adult hippocampus (Jones et al. (2015) Stem Cells. 33:196-210) and cerebellar granule neuron progenitors. We are currently working on identifying the mechanisms whereby the loss of CHD7 results in these defects. 


CHD8 and autism

Mutations in CHD8 have been implicated in a subtype of autism characterised by intellectual disability, macrocephaly, and additional craniofacial and gastro-intestinal defects. Recent estimates suggest that autism spectrum disorders affect approximately 1/110 children in the UK and up to 1/88 in the USA. We have produced new mouse and zebrafish models to investigate the functions of CHD8 in neural development and disease. 


Selected publications

Basson, M.A., Akbulut, S., Watson-Johnson J., Simon, R., Carroll, T.J., Shakya, R., Gross, I., Martin, G.R., Lufkin, T., McMahon, A.P., Wilson, P.D., Costantini, F.D., Mason, I.J. & Licht, J.D. (2005). Sprouty1 is a critical regulator of GDNF/Ret-mediated kidney induction. Developmental Cell 8: 229-239.

Basson, M.A., Echevarria, D., Peterson Ahn, C, Sudarov, A., Joyner, A.L., Mason, I.J., Martinez, S. & Martin, G.R. (2008) Specific regions within the embryonic midbrain and cerebellum require different levels of FGF signalling during development. Development 135: 889-898.

Randall, V., McCue, K., Roberts, C., Kyriakopoulou, V., Beddow, S., Vitelli, F., Prescott, K., Shaw-Smith, C., Devriendt, K., Bosman, E., Steffes, G., Steel, K., Simrick, S., Basson, M.A., Illingworth, E. & Scambler, P. (2009) Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J. Clin. Invest. 119: 3301-3310.

Yu, T., Yaguchi, Y., Echevarria, D., Martinez, S. & Basson, M.A.  (2011) Sprouty genes prevent excessive FGF signalling in multiple cell types throughout development of the cerebellum. Development 138: 2957-2968.

Simrick, S., Szumska, D., Gardiner, J., Jones, K., Sagar, K., Morrow, B., Bhattacharya, S. & Basson, M.A. (2012) Biallelic expression of Tbx1 protects the embryo from development defects caused by increased receptor tyrosine kinase signalling. Dev. Dyn. 241:1310-24.

Chakkalakal, J., Jones, K., Basson, M.A. & Brack, A.S. (2012) The aged niche disrupts muscle stem cell quiescence. Nature 490:355-360.

Basson, M.A. & Wingate, R.J. (2013) Congenital hypoplasia of the cerebellum: developmental causes and behavioural consequences. Front Neuroanat. 7:29.

Yu, T., Meiners, L.C., Danielsen, K., Wong, T.Y., Bowler, T., Reinberg, D., Scambler, P.J., van Ravenswaaij, C.M.A. & Basson, M.A. (2013) Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome. eLife 2:e01305.

Jones, K.M., Saric, N., Russell, J.P., Andoniadou, C.L., Scambler, P.J. & Basson, M.A. (2015) CHD7 maintains neural stem cell quiescence and prevents premature stem cell depletion in the adult hippocampus. Stem Cells. 33:196-210.

Full list of Publications

Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2019 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454